The Intravenous Vitamin Treatment That Destroys Cancer Cells

According to a study published in the journal Science Translational Medicine, an intravenous vitamin treatment may be the key to curing cancer. A team of researchers tested the effects of a common vitamin in high doses on a group of participants. They found that it was able to eradicate cancer cells while leaving healthy cells undamaged. The powerful vitamin used in the study? Vitamin C.

Intravenous Vitamin C May Be The Key To Cancer Treatment

The study involved injecting high doses of Vitamin C into human ovarian cells in a group of 22 human subjects. The results showed that Vitamin C effectively targeted ovarian cancer cells while avoiding healthy cells. Dr. Jeanne Drisko, a co-author of the study, explained, “Patients are looking for safe and low-cost choices in their management of cancer. Intravenous Vitamin C has that potential based on our basic science research and early clinical data.”

The next step in testing intravenous Vitamin C would be to conduct a large-scale clinical human trial. But the research team explained that a larger trial would require major funding. Funding for such trials typically comes from pharmaceutical companies that are interested in a pending drug. Since drug companies aren’t interested in promoting natural health through substances such as Vitamin C, the research team would most likely not be able to get the funding they need.

Qi Chen, lead author of the study, said, “Because Vitamin C has no patent potential, its development will not be supported by pharmaceutical companies. We believe that the time has arrived for research agencies to vigorously support thoughtful and meticulous clinical trials with intravenous Vitamin C.”

Vitamin C is processed differently by the body when administered in different ways, such as orally verses intravenously. Heidi Ledford explains in Nature, “Oral doses [of vitamin C] act as antioxidants, protecting cells from damage caused by reactive compounds that contain oxygen. But vitamin C given intravenously can have the opposite effect by promoting the formation of one of those compounds: hydrogen peroxide. Cancer cells are particularly susceptible to damage by such reactive oxygen-containing compounds.”